Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Clinical trial NCT01349049 · COMPLETED
Trial details
- NCT number
- NCT01349049
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-21
- Primary completion
- 2015-01-20
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.